Announcements Request Maharashtra Government to file review petition in Supreme Court : matter regarding Dr Payal Tadv [with 600+ endorsements]’.   |   POSITION AVAILABLE (FULL TIME) EDITORIAL COORDINATOR FOR Indian Journal of Medical Ethics (IJME)   |   A Joint Statement on Technical, legal, ethical and implementation concerns regarding Aarogya Setu and other apps introduced during COVID-19 in India by Jan Swasthya Abhiyan (JSA), Internet Freedom Foundation (IFF), Forum for Medical Ethics Society (FMES), and All India People’s Science Network (AIPSN)

Quality and corruption in the generic drug industry

Richard A Cash

DOI: 10.20529/IJME.2020.028


Abstract

In her book Bottle of lies: Ranbaxy and the dark side of Indian pharma, author Katherine Eban, clearly and convincingly sets out a case against the corruption that has infiltrated the generic drug industry, and Ranbaxy Ltd. in particular. The focus is on India, though many of the same arguments probably could be used for China, another major producer of generic drugs. Some elements in India, including government and the generic drug industry have struck back, accusing the author of maligning Indian pharma, and in the process, helping multinationals. Rather than “shooting the messenger”’ it might be best to address the issues that have been raised.

Full Text

HTML PDF

Keywords

N/A

Refbacks

There are currently no refbacks.

Article Views

PDF Downloads

Click here to support US